AdaptHealth Reports Q3 2026 Revenue of $745.65 Million, Net Loss
Revenue rose 10.9% year over year to $745.65 million. Net loss attributable to the company was $153.99 million, versus income of $24.51 million a year earlier; diluted loss per share was $1.13, compared with income of $0.17.
AdaptHealth reported third-quarter 2026 revenue of $745.65 million, up 10.9% from the prior-year quarter, while net income attributable to the company was a loss of $153.99 million compared with income of $24.51 million a year earlier. Diluted EPS was a loss of $1.13, versus income of $0.17 per sha…